VAERS Explorer
Back to explore

Report #2849283

Received Jul 18, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
Jul 1, 2025
Onset
Jul 2, 2025
Days to onset
1
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.1Y019158IM / LA
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNKY019158OT / LA

Symptoms (6)

Injection site erythemaInjection site reactionUrticariaFatigueInjection site painInjection site swelling

Symptom narrative

heavy fatigue; painful raised welt approx 2 x 4 inches centered on left deltoid injection site with 1 inch diameter rash; painful raised welt approx 2 x 4 inches centered on left deltoid injection site; This spontaneous report was received from a Patient on 02-Jul-2025 concerning his/herself of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 01-Jul-2025, the patient was vaccinated with a Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) (lot #Y019158, expiration date: 20-May-2026) (1 time), administered by Intramuscular route in the left deltoid for prophylaxis. On 02-Jul-2025, the patient experienced heavy fatigue, painful raised welt approximately 2 x 4 inches (Vaccination site urticaria, Vaccination site pain) centered on left deltoid injection site with 1 inch diameter rash on upper edge of armpit. The patient recovered from the events approximately on 07-Jul-2025, reported as lasted for lasted for 4-5 days. The causal relationship between the events and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) was unknown.